Timothy M Ullmann

7PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2025
The Landmark Series: Extent of Surgery for Low-Risk Differentiated Thyroid Cancer.

Timothy M Ullmann, Julie A Sosa

|Feb 15, 2023
Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.

Jessica Limberg, Caitlin E Egan, Katherine D Gray

|Nov 03, 2022
Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.

Timothy M Ullmann, Maria Papaleontiou, Julie Ann Sosa

|May 05, 2022
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.

Renuka Raman, Jacques A Villefranc, Timothy M Ullmann

|Mar 01, 2022
RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.

Timothy M Ullmann, Jessica W Thiesmeyer, Yeon Joo Lee

Pageof 2